同源域致癌基因驱动T-ALL向γδTCR表型分化偏移
在1233例T-ALL中,33%表达TCR,其中47%为γδTCR阳性。研究将γδTCR+ T-ALL分为两个亚型:皮质样γδ T-ALL(75%)由HOXA9或TLX3等含同源域致癌基因驱动向γδTCR分化偏移;真正的γδ T-ALL(25%)类似ETP-ALL且对BCL2抑制剂venetoclax敏感。
要点
- γδTCR+ T-ALL可分为皮质样(75%)和真正γδ(25%)两个亚型。
- HOXA9或TLX3转导使T细胞祖细胞向γδTCR表达偏移。
- 真正γδ T-ALL富集ETP样和KMT2A重排,对venetoclax敏感。
核心结论
- T-ALL中γδTCR表达存在发育异质性,含同源域致癌基因的过表达抑制αβ谱系定向从而富集γδTCR+表型。
研究设计与样本
- 研究分析了本中心1233例T-ALL的表型,其中403例表达TCR。
- γδTCR+ T-ALL共191例,包括113例成人和78例儿童。
- 结果在COGAALL0434队列中得到验证。
主要发现
- 1233例T-ALL中33%(n=403)表达TCR,其中47%(n=191)为γδTCR+。
- γδTCR+ T-ALL中75%为皮质样亚型,25%为真正γδ亚型。
- 转导HOXA9或TLX3可导致小鼠T细胞祖细胞和人CD34+细胞向γδTCR表达胸腺细胞分化偏移。
- 真正γδ T-ALL富集ETP样和KMT2A重排病例,且多数不符合ETP-ALL表型定义。
- 真正γδ T-ALL与ETP样亚型类似,初始化疗反应差,但对BCL2抑制剂venetoclax敏感。
临床怎么用
- 对γδTCR+ T-ALL应区分皮质样与真正γδ亚型,真正γδ亚型可考虑BCL2抑制剂venetoclax。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T-cell acute lymphoblastic leukemia (T-ALL) results from the malignant transformation of thymocytes blocked in their differentiation. Surface expression of the γδ T-cell receptor (γδTCR) is surprisingly frequent in T-ALLs, questioning the susceptibility of the γδ-lineage to leukemogenesis. Among 1233 T-ALLs phenotyped in our center, 33% (n = 403) expressed a TCR, of which 47% (n = 191; 113 adults, 78 children) were positive for γδTCR (γδTCR+). Using a comprehensive analysis, we were able to delineate 2 distinct γδTCR+ T-ALL subtypes, with distinct physiological counterparts. The first (75% of cases) was characterized by ectopic expression of homeodomain-containing oncogenes (HD+), Vβ-Jβ rearrangements, and phenotypic (including surface pre-TCRα chain) and transcriptional profiles reminiscent of cortical thymocytes and was, therefore, termed cortical-like γδ T-ALLs. Transduction of murine T-cell progenitors and human CD34+ cells with HOXA9 or TLX3 (HD+ oncogenes) led to a differentiation bias toward γδTCR-expressing thymocytes. The second subtype (25%) exhibited phenotypic and transcriptional profiles reminiscent of γδ thymocytes, and was termed bona fide γδ T-ALLs. These findings were validated in the COGAALL0434 cohort. Although bona fide γδ T-ALLs were enriched for early T-cell progenitor (ETP)-like and KMT2A-rearranged cases, they mostly eluded the phenotypic definition of ETP-ALLs. Similar to the ETP-like subtype, bona fide γδ T-ALLs were associated with a poor initial response to chemotherapy but were sensitive to the BCL2 inhibitor venetoclax. Our results reveal developmental heterogeneity behind γδTCR expression in T-ALLs and suggest that overrepresentation of this subtype reflects αβ-lineage commitment repression by HD+ oncogenes. These trials were registered at www.clinicaltrials.gov as NCT00222027 (GRAALL2003), NCT00327678 (GRAALL2005), NCT03709719 (GRAALL2014), and NCT00408005 (Children's Oncology Group AALL0434 trial).
引用
- Pinton A, Courtois L, Delafoy M, et al. Homeodomain-driven oncogenic diversion to a γδTCR phenotype in T-cell acute lymphoblastic leukemia. Blood. 2026. PMID: 41592282. doi:10.1182/blood.2025030626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。